nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—KCNH7—nervous system—Gilles de la Tourette syndrome	0.0606	0.115	CbGeAlD
Terazosin—KCNH7—central nervous system—Gilles de la Tourette syndrome	0.0583	0.111	CbGeAlD
Terazosin—KCNH7—brain—Gilles de la Tourette syndrome	0.0463	0.0878	CbGeAlD
Terazosin—KCNH6—nervous system—Gilles de la Tourette syndrome	0.0432	0.0818	CbGeAlD
Terazosin—KCNH6—central nervous system—Gilles de la Tourette syndrome	0.0416	0.0788	CbGeAlD
Terazosin—KCNH6—brain—Gilles de la Tourette syndrome	0.033	0.0625	CbGeAlD
Terazosin—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.0245	0.0463	CbGeAlD
Terazosin—ADRA1D—nervous system—Gilles de la Tourette syndrome	0.0239	0.0453	CbGeAlD
Terazosin—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.0235	0.0446	CbGeAlD
Terazosin—ADRA1D—central nervous system—Gilles de la Tourette syndrome	0.023	0.0436	CbGeAlD
Terazosin—ADRA1B—brain—Gilles de la Tourette syndrome	0.0187	0.0354	CbGeAlD
Terazosin—ADRA1D—brain—Gilles de la Tourette syndrome	0.0183	0.0347	CbGeAlD
Terazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0176	0.0373	CbGpPWpGaD
Terazosin—KCNH2—midbrain—Gilles de la Tourette syndrome	0.0161	0.0306	CbGeAlD
Terazosin—ADRA1D—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.015	0.0318	CbGpPWpGaD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0146	0.031	CbGpPWpGaD
Terazosin—ADRA1D—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0146	0.0309	CbGpPWpGaD
Terazosin—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.0137	0.026	CbGeAlD
Terazosin—ADRA1D—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0136	0.0288	CbGpPWpGaD
Terazosin—KCNH2—nervous system—Gilles de la Tourette syndrome	0.0133	0.0251	CbGeAlD
Terazosin—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.0132	0.0251	CbGeAlD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.013	0.0275	CbGpPWpGaD
Terazosin—KCNH2—central nervous system—Gilles de la Tourette syndrome	0.0128	0.0242	CbGeAlD
Terazosin—ADRA1D—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0126	0.0268	CbGpPWpGaD
Terazosin—ADRA1B—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0125	0.0264	CbGpPWpGaD
Terazosin—ADRA1D—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0123	0.026	CbGpPWpGaD
Terazosin—ADRA1B—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0121	0.0257	CbGpPWpGaD
Terazosin—KCNH7—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.0116	0.0246	CbGpPWpGaD
Terazosin—ADRA1D—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0114	0.0242	CbGpPWpGaD
Terazosin—ADRA1B—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0113	0.0239	CbGpPWpGaD
Terazosin—KCNH7—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.0113	0.0239	CbGpPWpGaD
Terazosin—ADRA1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0111	0.0235	CbGpPWpGaD
Terazosin—ADRA1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0108	0.0228	CbGpPWpGaD
Terazosin—KCNH7—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.0105	0.0223	CbGpPWpGaD
Terazosin—ADRA1A—brain—Gilles de la Tourette syndrome	0.0105	0.0199	CbGeAlD
Terazosin—ADRA1B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0105	0.0222	CbGpPWpGaD
Terazosin—ADRA1B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0102	0.0216	CbGpPWpGaD
Terazosin—KCNH2—brain—Gilles de la Tourette syndrome	0.0101	0.0192	CbGeAlD
Terazosin—ADRA1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.01	0.0212	CbGpPWpGaD
Terazosin—ADRA1D—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00952	0.0202	CbGpPWpGaD
Terazosin—ADRA1B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00949	0.0201	CbGpPWpGaD
Terazosin—ADRA1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00932	0.0197	CbGpPWpGaD
Terazosin—KCNH6—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00923	0.0196	CbGpPWpGaD
Terazosin—ADRA1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00905	0.0192	CbGpPWpGaD
Terazosin—ADRA1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00843	0.0178	CbGpPWpGaD
Terazosin—KCNH7—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00823	0.0174	CbGpPWpGaD
Terazosin—ADRA1D—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00801	0.0169	CbGpPWpGaD
Terazosin—ADRA1B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00791	0.0167	CbGpPWpGaD
Terazosin—ABCB1—midbrain—Gilles de la Tourette syndrome	0.00708	0.0134	CbGeAlD
Terazosin—ADRA1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00702	0.0149	CbGpPWpGaD
Terazosin—ADRA1D—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00668	0.0141	CbGpPWpGaD
Terazosin—ADRA1B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00665	0.0141	CbGpPWpGaD
Terazosin—ADRA1D—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00648	0.0137	CbGpPWpGaD
Terazosin—ADRA1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0059	0.0125	CbGpPWpGaD
Terazosin—ABCB1—nervous system—Gilles de la Tourette syndrome	0.00582	0.011	CbGeAlD
Terazosin—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.0056	0.0106	CbGeAlD
Terazosin—ABCB1—brain—Gilles de la Tourette syndrome	0.00445	0.00843	CbGeAlD
Terazosin—ADRA1D—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00423	0.00896	CbGpPWpGaD
Terazosin—KCNH2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00382	0.00809	CbGpPWpGaD
Terazosin—KCNH2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00349	0.00738	CbGpPWpGaD
Terazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0029	0.00614	CbGpPWpGaD
Terazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00282	0.00596	CbGpPWpGaD
Terazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00262	0.00556	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00249	0.00526	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00241	0.00511	CbGpPWpGaD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00241	0.0051	CbGpPWpGaD
Terazosin—ADRA1D—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00238	0.00503	CbGpPWpGaD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00234	0.00495	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00225	0.00476	CbGpPWpGaD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00218	0.00461	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00214	0.00453	CbGpPWpGaD
Terazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00213	0.0045	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00208	0.0044	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00206	0.00437	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.002	0.00424	CbGpPWpGaD
Terazosin—ADRA1B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00197	0.00418	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00193	0.0041	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00189	0.00401	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00187	0.00395	CbGpPWpGaD
Terazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00184	0.00389	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00184	0.00389	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00183	0.00388	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00178	0.00377	CbGpPWpGaD
Terazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00177	0.00374	CbGpPWpGaD
Terazosin—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00175	0.00371	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00171	0.00362	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00166	0.00351	CbGpPWpGaD
Terazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00157	0.00333	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00157	0.00333	CbGpPWpGaD
Terazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00157	0.00332	CbGpPWpGaD
Terazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00153	0.00323	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00153	0.00323	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00142	0.00301	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0014	0.00295	CbGpPWpGaD
Terazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00136	0.00287	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00136	0.00287	CbGpPWpGaD
Terazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00131	0.00277	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00126	0.00267	CbGpPWpGaD
Terazosin—ADRA1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.0012	0.00254	CbGpPWpGaD
Terazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00116	0.00246	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00107	0.00227	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00104	0.0022	CbGpPWpGaD
Terazosin—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000995	0.00211	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000972	0.00206	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000968	0.00205	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000943	0.002	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000888	0.00188	CbGpPWpGaD
Terazosin—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000884	0.00187	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000879	0.00186	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000862	0.00183	CbGpPWpGaD
Terazosin—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00086	0.00182	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000806	0.00171	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000803	0.0017	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000789	0.00167	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000783	0.00166	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000766	0.00162	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000729	0.00154	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000716	0.00152	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000713	0.00151	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000695	0.00147	CbGpPWpGaD
Terazosin—ADRA1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000678	0.00143	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000648	0.00137	CbGpPWpGaD
Terazosin—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000639	0.00135	CbGpPWpGaD
Terazosin—ADRA1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000615	0.0013	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000574	0.00122	CbGpPWpGaD
Terazosin—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000562	0.00119	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000557	0.00118	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000519	0.0011	CbGpPWpGaD
Terazosin—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000511	0.00108	CbGpPWpGaD
Terazosin—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.0005	0.00106	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000476	0.00101	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000462	0.000979	CbGpPWpGaD
Terazosin—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000454	0.000961	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000431	0.000912	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000423	0.000896	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000411	0.00087	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000383	0.00081	CbGpPWpGaD
Terazosin—ADRA1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000364	0.00077	CbGpPWpGaD
Terazosin—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000302	0.000639	CbGpPWpGaD
Terazosin—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000268	0.000567	CbGpPWpGaD
